Filing Details
- Accession Number:
- 0001225208-17-002641
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-08 12:11:21
- Reporting Period:
- 2017-02-06
- Filing Date:
- 2017-02-08
- Accepted Time:
- 2017-02-08 12:11:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1615418 | Beneficial Bancorp Inc. | BNCL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1396640 | P Gerard Cuddy | 1818 Market Street Philadelphia PA 19103 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-06 | 132,983 | $10.78 | 144,343 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-06 | 132,983 | $16.42 | 11,360 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-02-07 | 30,000 | $10.78 | 41,360 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-07 | 30,000 | $16.08 | 11,360 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-06 | 132,983 | $0.00 | 132,983 | $10.78 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-07 | 30,000 | $0.00 | 30,000 | $10.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
86,997 | 2018-08-06 | No | 4 | M | Direct | |
56,997 | 2018-08-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 23,185 | Indirect | By IRA |
Common Stock | 26,265 | Indirect | By KSOP |
Common Stock | 35,000 | Indirect | Restricted Stock IX |
Common Stock | 4,400 | Indirect | Restricted Stock V |
Common Stock | 4,400 | Indirect | Restricted Stock VI |
Common Stock | 21,998 | Indirect | Restricted Stock VII |
Common Stock | 31,000 | Indirect | Restricted Stock VIII |
Common Stock | 498,000 | Indirect | Restricted Stock X |
Common Stock | 22,707 | Indirect | Restricted Stock XI |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $7.59 | 2019-03-09 | 16,498 | 16,498 | Direct | |
Common Stock | Stock Option (Right to Buy) | $7.62 | 2021-05-27 | 32,997 | 32,997 | Direct | |
Common Stock | Stock Option (Right to Buy) | $8.30 | 2022-03-23 | 82,492 | 82,492 | Direct | |
Common Stock | Stock Option (Right to Buy) | $8.40 | 2023-01-17 | 82,492 | 82,492 | Direct | |
Common Stock | Stock Option (Right to Buy) | $8.82 | 2020-03-05 | 16,498 | 16,498 | Direct | |
Common Stock | Stock Option (Right to Buy) | $10.77 | 2024-02-20 | 82,492 | 82,492 | Direct | |
Common Stock | Stock Option (Right to Buy) | $11.41 | 2025-02-06 | 47,541 | 47,541 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2019-03-09 | 16,498 | 16,498 | Direct |
2021-05-27 | 32,997 | 32,997 | Direct |
2022-03-23 | 82,492 | 82,492 | Direct |
2023-01-17 | 82,492 | 82,492 | Direct |
2020-03-05 | 16,498 | 16,498 | Direct |
2024-02-20 | 82,492 | 82,492 | Direct |
2025-02-06 | 47,541 | 47,541 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.40 to $16.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This form reflects an increase in beneficial ownership resulting from an exempt acquisition pursuant to Rule 16b-3(c).
- These restricted shares are subject to a three-year cliff vesting schedule whereby no shares vest on the first and second anniversaries of the award, 60% of the shares vest on January 28, 2019, the third anniversary of the award, and thereafter, 20% of the shares each vest on the fourth and fifth anniversaries of the award.
- These restricted shares are subject to a three-year cliff vesting schedule whereby no shares vest on the first and second anniversaries of the award, 60% of the shares vest on March 23, 2015, the third anniversary of the award, and thereafter, 20% of the shares each vest on the fourth and fifth anniversaries of the award.
- These restricted shares are subject to a three-year cliff vesting schedule whereby no shares vest on the first and second anniversaries of the award, 60% of the shares vest on January 17, 2016, the third anniversary of the award, and thereafter, 20% of the shares each vest on the fourth and fifth anniversaries of the award.
- These restricted shares are subject to a three-year cliff vesting schedule whereby no shares vest on the first and second anniversaries of the award, 60% of the shares vest on February 20, 2017, the third anniversary of the award, and thereafter, 20% of the shares each vest on the fourth and fifth anniversaries of the award.
- These restricted shares are subject to a three-year cliff vesting schedule whereby no shares vest on the first and second anniversaries of the award, 60% of the shares vest on February 06, 2018, the third anniversary of the award, and thereafter, 20% of the shares each vest on the fourth and fifth anniversaries of the award.
- Shares of restricted stock vest in 3 equal annual installments with the first 33 1/3% vesting on June 9, 2017, the first anniversary of the date of the award.
- Of the 22,707 shares granted, 13,624 shares will fully vest on January 26, 2020 upon the satisfaction of company performance criteria related to credit quality, return on average assets and total shareholder return. The remaining 9,083 shares are subject to vesting in 3 equal annual installments with the first 33 1/3% vesting on January 26, 2018, the first anniversary of the date of the award.
- Stock options are fully vested and exercisable.
- Stock options vest in 5 equal annual installments with the first 20% vesting on March 23, 2013, the first anniversary of the date of the grant.
- Stock options vest in 5 equal annual installments with the first 20% vesting on January 17, 2014, the first anniversary of the date of the grant.
- Stock options vest in 5 equal annual installments with the first 20% vesting on February 20, 2015, the first anniversary of the date of the grant.
- Stock options vest in 5 equal annual installments with the first 20% vesting on February 6, 2016, the first anniversary of the date of the grant.